216 related articles for article (PubMed ID: 23899286)
1. Advancements in pancreatic neuroendocrine tumors.
Sadaria MR; Hruban RH; Edil BH
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):477-90. PubMed ID: 23899286
[TBL] [Abstract][Full Text] [Related]
2. Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.
Hauser H; Gerson DS; Reidy-Lagunes D; Raj N
Curr Treat Options Oncol; 2019 Nov; 20(12):87. PubMed ID: 31776785
[TBL] [Abstract][Full Text] [Related]
3. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors: a comprehensive review.
Zhou C; Zhang J; Zheng Y; Zhu Z
Int J Cancer; 2012 Sep; 131(5):1013-22. PubMed ID: 22437917
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
6. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
Cloyd JM; Poultsides GA
World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis.
Pozzari M; Maisonneuve P; Spada F; Berruti A; Amoroso V; Cella CA; Laffi A; Pellicori S; Bertani E; Fazio N
Cancer Treat Rev; 2018 Dec; 71():39-46. PubMed ID: 30352319
[TBL] [Abstract][Full Text] [Related]
8. Metastatic pancreatic neuroendocrine tumors (pNET): placing current findings into perspective.
Phan AT
Cancer Treat Rev; 2013 Feb; 39(1):3-9. PubMed ID: 22459199
[TBL] [Abstract][Full Text] [Related]
9. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Pea A; Hruban RH; Wood LD
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
[TBL] [Abstract][Full Text] [Related]
10. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumours: clinical presentation and management of localized disease.
Kulke MH
Cancer Treat Rev; 2003 Oct; 29(5):363-70. PubMed ID: 12972355
[TBL] [Abstract][Full Text] [Related]
12. Surgery in malignant pancreatic neuroendocrine tumors.
Nguyen SQ; Angel LP; Divino CM; Schluender S; Warner RR
J Surg Oncol; 2007 Oct; 96(5):397-403. PubMed ID: 17469119
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors.
Krampitz GW; Norton JA
Curr Probl Surg; 2013 Nov; 50(11):509-45. PubMed ID: 24206780
[No Abstract] [Full Text] [Related]
14. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
[No Abstract] [Full Text] [Related]
15. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
Crippa S; Partelli S; Zamboni G; Scarpa A; Tamburrino D; Bassi C; Pederzoli P; Falconi M
Surgery; 2014 Jan; 155(1):145-53. PubMed ID: 24646958
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors of the pancreas.
Milan SA; Yeo CJ
Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
[TBL] [Abstract][Full Text] [Related]
17. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
[TBL] [Abstract][Full Text] [Related]
18. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.
Grandhi MS; Lafaro KJ; Pawlik TM
J Gastrointest Surg; 2015 Dec; 19(12):2273-82. PubMed ID: 26341823
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.
Folkert IW; Hernandez P; Roses RE
World J Gastroenterol; 2016 Mar; 22(11):3105-16. PubMed ID: 27003988
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors of the pancreas.
Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
